Articles

A study by the University of Michigan identifies why people with glioma, a type of tumor, tend to live much longer than others. The research was funded by the National Institutes of Health, which suggested that the combination of radiation therapy against cancer to block DNA repair could be an effective treatment. Some patients are less aggressive and can repair DNA better than others, but they are difficult to eliminate by radiation. The research article was published on February 13, 2019 in the journal Science Translation Magazine. Researchers have focused on low-grade gliomas. These gliomas are carriers of a disease that causes changes in a gene called isocitrate dehydrogenase 1 (IDH1). These changes are found in about 50% of cases with low levels of primary glioma. Findings According to the research, patients with glioma have changes in IDH1 are mostly of young age. In addition, they live longer than patients with normal genes. The experiment was performed by replicating the patient’s tumor by genetic programming of mice to increase cancer cells in the brain. These cells carry pathogenic mutations in IDH1 as well as mutations in TP53 (a tumor suppressor gene) and ATRX (a DNA-protein complex remodeling gene). In terms of patients, the results of the study showed that mice programmed to develop brain cells tend to live longer than control mice when the tumors were programmed for normal IDH1. The study also showed that the IDH1 mutation had made the glioma cells less aggressive. When implanted in the brain of mice, it was very likely that cell division increased tumor growth at lower rates. IDH1 mutations as well as mutations of the TP53 and ATRX genes lead to the resistance of the tumor to ionizing radiation. This treatment often damages the DNA by killing the cells. Subsequent studies have shown that IDH1 alters activity due to a pathogenic mutation. For this reason, several chemical reactions that alter the genes of the cancerous cells begin in a way that increases the production of a protein that can repair the damaged DNA. Dr. Maria G. Castro, professor of neurosurgery at Michigan Medicine and principal author of the study, said, “Our team’s mission is to find life-saving treatments for these patients. The results from this study could be a blueprint for extending, if not saving, the lives of many patients.” Dr. Jane Fountain, a presenter at the National Institute of Neurological Diseases and Stroke at NIH, said: “These findings have the potential to impact many younger glioma patients with low-grade tumors by either ‘curing’ them or extending their lives, the preclinical model Dr. Castro’s team developed will be extremely valuable to cancer researchers. It closely mirrors the human disease.” In this study, researchers formulated and experimented with a new combination therapy. They found that mice exposed to mutated IDH1 tumors with radiation and injected with cancer drugs to prevent DNA repair can prolong life. In contrast, mice showed no side effects when treated or radiated individually. Similar results were observed in human gliomas grown in a Petri dish.

According to Israeli researchers, they are likely to cure cancer within one year, according to The Jerusalem Post. Cancer is an abnormal growth of cells. There are more than 100 types, including skin cancer, lung cancer, breast cancer and colon cancer, and the disease is the second leading cause of death in the United States. More than half a million people died of cancer in 2015, 1.7% less than in 2014. This sounds fantastic, especially when 18.1 million new cancers are diagnosed each year worldwide, according to reports from the International Cancer Research Board. One in six cancer worldwide is caused by cancer, making it the second cause of death (the second cause of death after cardiovascular disease). Aridor, CEO of AEBi and CEO Ilan Morad, explains that their treatment, which they call MuTaTo (multi-target toxin), is essentially the extension of an anti-cancer antibiotic, an advanced technology in the first order. The multi-measurement toxin treatment developed by an Israeli company has questioned the declared capacity to cure cancer. Ilan Morad, CEO of Codeveloper and the company, recently expressed confidence in an interview with Xinhua. The anti-cancer drug that can change the game is based on SoAP technology, which is part of the subject-display technology group. DNA encoding a protein, as an antibody, is introduced into a bacteriophage, a virus that infects bacteria. This protein is shown on the surface of the phage. Researchers can use these protein-presenting subjects to look for interactions with other proteins, DNA sequences, and small molecules. In 2018 a team of researchers won the Nobel Prize for their work in the subject field in the directed development of new proteins, especially for the production of antibody-based drugs. AEBi works in a similar manner but with peptides composed of two or more amino acids linked in a chain. According to Morad, peptides have several advantages over antibodies, including the fact that they are smaller, cheaper and easier to prepare and regulate. When the company started, Morad said, “We did exactly the same as everyone else, and we tried to discover new individual peptides for some types of cancer.” Shortly afterwards, Morad and his colleague, Dr. Hanan Itzhaki, wanted to do something bigger. “We make sure that the treatment is not affected by the mutations and that the cancer cells can mutate for cancer to start specific receptors.” Morad said the company has so far completed its first experimental experiment in mice that inhibited the growth of human cancer cells and had no effect on cells from healthy mice, as well as several in vitro studies. AEBi should begin a series of clinical trials that may be conducted in a few years, and in some cases it will make the treatment available. “The probability of having multiple mutations that would modify all the targeted receptors decreases dramatically with the number of targets used,” Morad continued. “Instead of attacking the receivers one at a time, we attack the receivers three at a time; even cancer cannot mutate three receptors at the same time.” Aridor said: “Our results are consistent and repeatable.” It will take several years and a big investment, and there have been many “sleep medications” that do not work as expected when tested in humans, he said.

If you’re contemplating having a surgery or your GP has indicated you may require surgery, this manual is for you. It’ll take you through all the steps in the procedure, from referral to recovery, and that means you’re fully ready and know what questions to ask at each stage. Prior to starting, you will need to decide which hospital you would love to be known. Our hints on picking a hospital can help. These steps will help make your surgery safer: Quit smoking, at least for the surgery. It’s important not to smoke on the day of your surgery. The earlier you quit, the lower your risk of complications. Should you need help quitting, ask your health care provider. Ask your healthcare provider about your blood counts. If your red blood cell counts are low, ask your health care provider about whether simple remedies like iron may be used to boost your red blood cells for operation. That way, you can lessen the risk of having a blood transfusion. Ask about pain relief. Ask your healthcare  provider you should stop aspirin or other blood thinners. You may want to use acetaminophen for pain relief. Avoid ibuprofen and naproxen sodium because they can lead to bleeding. Ask someone to drive you to and from the hospital and stay overnight with you. You may choose to ask someone to be with you at your health care provider’s appointments, especially in stressful circumstances, to be sure all directions and advice is retained. Ask about nursing or rehabilitation care, too. Common Tests Before and After Surgery Blood Tests Coagulation Research : These evaluations are done to determine how well (how fast) your blood clots. Clotting too slowly can mean greater bleeding, clotting too fast can raise the chance of blood clots after surgery. Blood Chemistry: The comprehensive blood chemistry appears at several different areas of your overall health, including your own blood glucose (sugar) level, your kidney function, and also the levels of potassium, sodium, and chloride in your bloodstream. These amounts may be employed to maximize your health in the weeks prior to surgery or through your recovery. Complete Blood Count: The complete blood count looks at he various elements of blood, such as red and white blood cells, and determines whether they are present in appropriate numbers. This test can ascertain if certain difficulties, such as nausea, are present. Liver Enzymes: Liver enzymes are used to ascertain how well the liver is working, if it can perform its role removing medicines from your system, and may indicate whether the liver has been damaged. Cardiac Enzymes: Cardiac enzymes are evaluations that are done to determine the current health of the muscles which comprise the heart. These tests are usually done to determine whether a heart attack is in progress and can also help determine if chest pain is being caused by a heart attack. This test can ascertain whether the ventilator settings are appropriate for the individual and also how well the patient is utilizing oxygen. Imaging Tests Imaging tests are tests used to visualize the inside of your body without doing surgery. Even though a few of those tests may require an injection of IV contrast, many are noninvasive, meaning they are done from afar. There’s a wide range of evaluations that are frequently performed before and after surgery, and here are a Couple of of the most common: CT Scan A CT scan is a common, non-invasive test that generates a 3-D picture of the area scanned. It’s used to diagnose illnesses and results may be used to ascertain the ideal treatment. MRI: A MRI is another type of non-invasive test that is used to create a 3-D image of the area scanned. It may be employed to ascertain a diagnosis and a plan of therapy. The MRI requires the patient to lay on a bed which then moves to the tube-like machine. For large patients or claustrophobic people, an open MRI is often available in bigger cities. Ultrasoundthe majority of individuals are familiar with ultrasound from pregnancy scans for fetal health and development. Ultrasound can also be utilized for a vast array of motives, from looking for a DVT in the leg to analyzing breast tissue. Endoscopy: Endoscopy is the overall name for a process in which a tool with a light and a camera is used to take a look at the interior of the human body. An upper endoscopy, for example, is when the tool is inserted into the mouth and throughout the GI tract. These procedures allow the physician to visualize the inside of organs without surgery. PET Scan: A PET scan is a test which uses a radionuclide tracer to provide pictures of the interior of the human body. The evaluation is noninvasive but does demand the insertion of an IV to administer the radionuclide. Sometimes, the PET scan is completed along with a CT scan for the best possible images. X-rays can help diagnose causes of shortness of breath, chest discomfort, cough, and specific fevers. They can also help diagnose abnormal heart, breathing, and lung sounds. Electrocardiogram (ECG). This test records the electrical activity of the heart. It shows abnormal rhythms (arrhythmias or dysrhythmias), finds heart muscle damage, and helps find the cause of chest pain, fluttering heartbeats (palpitations), and heart murmurs. Urinalysis. Particular sorts of urinalysis may also find illegal drugs within the body. This test will help diagnose specific fevers and infections. It can also find out if someone is using medications that affect white blood counts. You may also want one or more of the following blood tests prior to surgery: Glucose. This evaluation measures your blood sugar levels. Potassium. This test measures the quantity of sodium, potassium, and other electrolytes in your blood. These chemicals help regulate heart rhythms and other body functions. Complete blood count (CBC). This test checks for a low number of red blood cells (anemia) and disease. These evaluations find out how well your blood clots.